 |
|
In this educational symposium, a breast cancer oncologist will
present an overview of the current role of targeted therapies
used in the treatment of breast cancer and provide an update
on emerging clinical trial data expected to markedly influence
practice patterns. The focus will be on issues that affect nurses
most, such as agents they can expect to administer, and
dosing and scheduling modifications based on new data. The
latter half of the program will consist of an interactive workshop
in which an expert panel of breast cancer oncology nurses will
present and discuss model algorithms for assessing and
managing common toxicities specific to breast cancer targeted
therapies. An interactive question-and-answer activity will lead
participants through common toxicity management algorithms
and will help to identify barriers (i.e., institutional, personal,
cultural) to algorithm implementation. Strategies for overcoming
these barriers will be identified and discussed, ultimately
providing attendees with a working model for incorporating up-to-date standards into their routine nursing practices. Program
attendees will receive several side-effect assessment and
management clinical tools, as well as sample patient education
tools, to utilize in their individual clinical practices.
|
